5 hours agoGermany begins testing anti-Cavid-19 human vaccine
Periskopi(6 years ago)
(6 years ago)The American pharmaceutical giant Pfizer and German company BioNTech have begun testing human anti-corranvirus vaccines, which could be available to millions of people by the end of the year, says company statement. Pfizer announced that experimental vaccines in the United States will start testing next week and will [...]
The American pharmaceutical giant Pfizer and German company BioNTech have begun testing human anti-corranvirus vaccines, which could be available to millions of people by the end of the year, says company statement.
Pfizer announced that experimental vaccines in the United States will begin testing next week and will be ready for immediate use in the autumn, Wall Street Journal reported on Tuesday.
However, BioNTech reports that a number of people have already received a dose of BNT162 potential vaccine as part of a clinical study, Telegraphy broadcast.
Twelve people have already been vaccinated, about 200 healthy volunteers will receive the vaccine.
Twelve people have so far been vaccinated in Germany with the BNT162 vaccine against COVID-19, and there is no information on the results of this test, CNN writes.
BioNTech says that about 200 healthy volunteers between the ages of 18 and 55 in the United States will receive a dose of 1 microgram to 100 micrograms to find optimial doses for further studies.
This is a very good sign that we can start clinical testing now. Of course, security is an important guide for us and testing will take months. Security is key when it comes to this kind of vaccine”, German Health Minister Jens Spahn noted several days ago.
